CIC
DNA icon

Carnegie Investment Counsel’s Ginkgo Bioworks DNA Stock Holding History

Carnegie Investment Counsel’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-758
Closed -$95K – 515
2022
Q3 		$95K Buy
+758
New +$90.3K ﹤0.01% 467
2022
Q2 		– Sell
-3,781
Closed -$609K – 479
2022
Q1 		$609K Sell
3,781
-290
-7% -$56.4K 0.02% 324
2021
Q4 		$1.35M Buy
4,071
+797
+24% +$379K 0.04% 247
2021
Q3 		$1.52M Buy
+3,274
New +$1.59M 0.06% 209

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return